BIOTRONIK Wins Cardiostim Innovation Award for Best Practice Improvement with MRI AutoDetect Feature

MRI AutoDetect Enables Ilivia Implantable Cardioverter Defibrillators and Cardiac Resynchronization Devices to Automatically Recognize and Adapt to MRI Environment
BIOTRONIK winner of Cardiostim Award 2016 (PresseBox) (Nice, France and Berlin, Germany, ) BIOTRONIK has won the Cardiostim Innovation Award in the category “Best Practice Improvement” for its MRI AutoDetect feature. The company’s Ilivia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization device (CRT-Ds) are the world’s first equipped with a sensor capable of automatically recognizing a magnetic resonance imaging (MRI) environment.

MRI AutoDetect allows cardiologists to activate a special window lasting up to 14 days, during which all normal device functionality is maintained until a unique built-in sensor detects the presence of an MRI scanner. Once activated, the sensor automatically detects the MR environment and activates a predefined MRI mode, which necessarily entails limited device therapy. When the patient leaves the MR environment, the device automatically reactivates the permanent program, thus limiting the time in MRI mode to an absolute minimum. Once the scan is complete, all device functionality is restored without the need for the cardiologist’s intervention. Soon after, the cardiologist can receive a full report transmitted via BIOTRONIK Home Monitoring®.

This represents a significant advance over the current situation, in which patients go unprotected by full ICD functionality for longer than the actual scanning procedure lasts. Reducing the amount of time a patient’s ICD and CRT-D spends in MRI mode is particularly crucial, as dangerous arrhythmias requiring defibrillation can strike at any time. With MRI AutoDetect the only time patients do not benefit from full device therapy is during the relatively short time spent in the scanner itself.

“MRI AutoDetect exemplifies the spirit of innovation that thrives at BIOTRONIK,” commented Manuel Ortega, Senior Vice President at BIOTRONIK. “It is a crucial improvement over current standard practice on two counts—it helps improve efficiency and streamline workflows between radiologists and cardiologists, while, most importantly, keeping patients safer by reducing the amount of time their device is in MRI mode. We are honored at this recognition of our steadfast commitment to advancing patient care beyond the implant.”

About ProMRI

BIOTRONIK ProMRI technology enables patients with a pacemaker, implantable defibrillator, cardiac monitor, or cardiac resynchronization therapy defibrillator (CRT-D) or pacemaker (CRT-P) to undergo an MRI scan. Devices with MRI AutoDetect have the additional capability of automatically recognizing an MR environment within a programmable time window, switching on the device’s MRI mode for only as long as is required to complete the scan, about 30 minutes. This ensures the patient receives the full benefit of their device for the maximum amount of time possible. BIOTRONIK has the broadest portfolio of cardiac devices approved for use in the MR environment on the market. For more details, please go to www.biotronik.com/promri.

Kontakt

BIOTRONIK
Woermannkehre 1
D-12359 Berlin
Manuela Schildwächter
BIOTRONIK SE & Co. KG
Communications & PR Manager

Bilder

Social Media